Immunologic and Hematologic Reconstitution After Allogeneic Bone Marrow Transplantation
Authors:
- H. Joachim DeegHDH. Joachim Deeg
- Lawrence G. LumLLLawrence G. Lum
- Jean SandersJSJean Sanders
- Gary J. LevyGLGary J. Levy
- Keith M. SullivanKSKeith M. Sullivan
- Patrick BeattyPBPatrick Beatty
- E. Donnall ThomasETE. Donnall Thomas
- Rainer StorbRSRainer Storb
- 1 May 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 41 (5) , 583-586
Abstract
Chronic mucocutaneous candidiasis (CMC) is typically associated with the inability of T lymphocytes to proliferate and produce lymphokines in response to Candida antigen. A 7-year-old girl with CMC developed severe aplastic anemia and, after conditioning with cyclophosphamide, 200 mg/kg, underwent bone marrow transplantation from her HLA-identical sister. Engraftment was prompt and complete. Te patient is surviving more than 3 years after transplantation with normal donorderived hemopoiesis and immune function. Manifestations o CMC have resolved completely and she has not received antifungal therapy for more than 2 years.Keywords
This publication has 4 references indexed in Scilit:
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionBlood, 1981
- Functional properties of human T cells bearing Fc receptors for IgA. I. Mitogen responsiveness, mixed lymphocyte culture reactivity, and helper activity for B cell immunoglobulin production.The Journal of Immunology, 1980
- Cimetidine as an Immunomodulator: Chronic Mucocutaneous Candidiasis as a ModelAnnals of Internal Medicine, 1980
- Subpopulations of human T lymphocytesClinical Immunology and Immunopathology, 1979